Could Cetuximab Maintenance Play a Role in RAS Wild-Type Metastatic CRC?
Maintenance therapy with cetuximab (Erbitux) after FOLFIRI (leucovorin, fluorouracil, and irinotecan) plus cetuximab induction therapy led to better outcomes for ...
Read moreDetails